Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 11.822
Filtrer
1.
Environ Health ; 23(1): 60, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38951908

RÉSUMÉ

BACKGROUND: Gestational exposure to toxic environmental chemicals and maternal social hardships are individually associated with impaired fetal growth, but it is unclear whether the effects of environmental chemical exposure on infant birth weight are modified by maternal hardships. METHODS: We used data from the Maternal-Infant Research on Environmental Chemicals (MIREC) Study, a pan-Canadian cohort of 1982 pregnant females enrolled between 2008 and 2011. We quantified eleven environmental chemical concentrations from two chemical classes - six organochlorine compounds (OCs) and five metals - that were detected in ≥ 70% of blood samples collected during the first trimester. We examined fetal growth using birth weight adjusted for gestational age and assessed nine maternal hardships by questionnaire. Each maternal hardship variable was dichotomized to indicate whether the females experienced the hardship. In our analysis, we used elastic net to select the environmental chemicals, maternal hardships, and 2-way interactions between maternal hardships and environmental chemicals that were most predictive of birth weight. Next, we obtained effect estimates using multiple linear regression, and plotted the relationships by hardship status for visual interpretation. RESULTS: Elastic net selected trans-nonachlor, lead, low educational status, racially minoritized background, and low supplemental folic acid intake. All were inversely associated with birth weight. Elastic net also selected interaction terms. Among those with increasing environmental chemical exposures and reported hardships, we observed stronger negative associations and a few positive associations. For example, every two-fold increase in lead concentrations was more strongly associated with reduced infant birth weight among participants with low educational status (ß = -100 g (g); 95% confidence interval (CI): -215, 16), than those with higher educational status (ß = -34 g; 95% CI: -63, -3). In contrast, every two-fold increase in mercury concentrations was associated with slightly higher birth weight among participants with low educational status (ß = 23 g; 95% CI: -25, 71) compared to those with higher educational status (ß = -9 g; 95% CI: -24, 6). CONCLUSIONS: Our findings suggest that maternal hardships can modify the associations of gestational exposure to some OCs and metals with infant birth weight.


Sujet(s)
Poids de naissance , Polluants environnementaux , Hydrocarbures chlorés , Exposition maternelle , Humains , Femelle , Grossesse , Hydrocarbures chlorés/sang , Poids de naissance/effets des médicaments et des substances chimiques , Adulte , Polluants environnementaux/sang , Canada , Nouveau-né , Jeune adulte , Métaux/sang , Facteurs socioéconomiques , Études de cohortes , Mâle
2.
Environ Sci Pollut Res Int ; 31(29): 42264-42276, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38865044

RÉSUMÉ

The relationship between exposure to air pollutants and fetal growth outcomes has shown inconsistency, and only a limited number of studies have explored the impact of air pollution on gestational hypertension and birth outcomes. This study aimed to evaluate how maternal exposure to air pollutants and blood pressure could influence fetal birth outcomes. A total of 55 women with gestational hypertension and 131 healthy pregnant women were enrolled in this study. Data pertaining to personal characteristics, prenatal examinations, outdoor air pollutant exposure, and fetal birth outcomes were collected. The study revealed that fetal birth weight and abdominal circumference exhibited a significant reduction among women with gestational hypertension compared to healthy pregnant women, even after adjustments for body mass index, gestational age, and exposure to air pollutants had been made. Moreover, maternal exposure to outdoor air pollutants displayed a notable correlation with decreased birth length of fetuses. Consequently, the study concluded that maternal blood pressure and exposure to outdoor air pollutants during pregnancy potentially stand as pivotal factors influencing fetal birth outcomes.


Sujet(s)
Polluants atmosphériques , Pollution de l'air , Hypertension artérielle gravidique , Exposition maternelle , Humains , Grossesse , Femelle , Adulte , Pollution de l'air/effets indésirables , Poids de naissance , Issue de la grossesse , Nouveau-né
3.
Environ Sci Technol ; 58(26): 11320-11330, 2024 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-38898774

RÉSUMÉ

Placental DNA methylation (DNAm) may be a potential mechanism underlying the effects of prenatal bisphenol analogues (BPs) exposure on reproductive health. Based on the Shanghai-Minhang Birth Cohort Study (S-MBCS), this study investigated associations of placental DNAm at reproduction-related genes with prenatal BPs exposure and children's digit ratios at age 4 using multiple linear regression models, and mediation analysis was further used to examine the mediating role of placental DNAm in the associations between prenatal BPs exposure and digit ratios among 345 mother-child pairs. Prenatal exposure to bisphenol A (BPA) was associated with hypermethylation at Protocadherin 8 (PCDH8), RBMX Like 2 (RBMXL2), and Sperm Acrosome Associated 1 (SPACA1), while bisphenol F (BPF) exposure was associated with higher methylation levels of Fibroblast Growth Factor 13 (FGF13). Consistent patterns were found in associations between higher DNAm at the 4 genes and increased digit ratios. Further mediation analysis showed that about 15% of the effect of BPF exposure on increased digit ratios was mediated by placental FGF13 methylation. In conclusion, the altered placental DNAm status might be a mediator underlying the feminizing effect of prenatal BPs exposure.


Sujet(s)
Méthylation de l'ADN , Phénols , Placenta , Humains , Femelle , Grossesse , Placenta/effets des médicaments et des substances chimiques , Placenta/métabolisme , Phénols/toxicité , Études de cohortes , Effets différés de l'exposition prénatale à des facteurs de risque , Mâle , Composés benzhydryliques , Cohorte de naissance , Reproduction/effets des médicaments et des substances chimiques , Exposition maternelle , Adulte , Doigts/anatomie et histologie , Enfant d'âge préscolaire
4.
J Hazard Mater ; 475: 134863, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38885590

RÉSUMÉ

Early life phthalates exposure has been associated with adverse respiratory outcomes. However, evidence linking prenatal phthalates exposure and childhood lung function has been inconclusive. Additionally, few studies have examined phthalates exposure as a mixture and explored sexually dimorphic associations. We aimed to investigate sex-specific associations of prenatal phthalates mixtures with childhood lung function using the PROGRESS cohort in Mexico (N = 476). Prenatal phthalate concentrations were measured in maternal urine collected during the 2nd and 3rd trimesters. Children's lung function was evaluated at ages 8-13 years. Individual associations were assessed using multivariable linear regression, and mixture associations were modeled using repeated holdout WQS regression and hierarchical BKMR; data was stratified by sex to explore sex-specific associations. We identified significant interactions between 2nd trimester phthalates mixture and sex on FEV1 and FVC z-scores. Higher 2nd trimester phthalate concentrations were associated with higher FEV1 (ß = 0.054, 95 %CI: 0.005, 0.104) and FVC z-scores (ß = 0.074, 95 % CI: 0.024, 0.124) in females and with lower measures in males (FEV1, ß = -0.017, 95 %CI: -0.066, 0.026; FVC, ß = -0.014, 95 %CI: -0.065, 0.030). This study indicates that prenatal exposure to phthalates is related to childhood lung function in a sex-specific manner.


Sujet(s)
Poumon , Acides phtaliques , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Acides phtaliques/urine , Acides phtaliques/toxicité , Femelle , Enfant , Mexique , Mâle , Grossesse , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Adolescent , Poumon/effets des médicaments et des substances chimiques , Poumon/physiopathologie , Exposition maternelle/effets indésirables , Polluants environnementaux/urine , Polluants environnementaux/toxicité , Tests de la fonction respiratoire
5.
Int J Hyg Environ Health ; 260: 114405, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38878407

RÉSUMÉ

Zearalenone (ZEN) is a fungal-derived toxin found in global food supplies including cereal grains and processed foods, impacting populations worldwide through diet. Because the chemical structure of ZEN and metabolites closely resembles 17ß-estradiol (E2), they interact with estrogen receptors α/ß earning their designation as 'mycoestrogens'. In animal models, gestational exposure to mycoestrogens disrupts estrogen activity and impairs fetal growth. Here, our objective was to evaluate relationships between mycoestrogen exposure and sex steroid hormone concentrations in maternal circulation and cord blood for the first time in humans. In each trimester, pregnant participants in the UPSIDE study (n = 297) provided urine for mycoestrogen analysis and serum for hormone analysis. At birth, placental mycoestrogens and cord steroids were measured. We fitted longitudinal models examining log-transformed mycoestrogen concentrations in relation to log-transformed hormones, adjusting for covariates. Secondarily, multivariable linear models examined associations at each time point (1st, 2nd, 3rd trimesters, delivery). We additionally considered effect modification by fetal sex. ZEN and its metabolite, α-zearalenol (α-ZOL), were detected in >93% and >75% of urine samples; >80% of placentas had detectable mycoestrogens. Longitudinal models from the full cohort exhibited few significant associations. In sex-stratified analyses, in pregnancies with male fetuses, estrone (E1) and free testosterone (fT) were inversely associated with ZEN (E1 %Δ: -6.68 95%CI: -12.34, -0.65; fT %Δ: -3.22 95%CI: -5.68, -0.70); while α-ZOL was positively associated with E2 (%Δ: 5.61 95%CI: -1.54, 9.85) in pregnancies with female fetuses. In analysis with cord hormones, urinary mycoestrogens were inversely associated with androstenedione (%Δ: 9.15 95%CI: 14.64, -3.30) in both sexes, and placental mycoestrogens were positively associated with cord fT (%Δ: 37.13, 95%CI: 4.86, 79.34) amongst male offspring. Findings support the hypothesis that mycoestrogens act as endocrine disruptors in humans, as in animal models and livestock. Additional work is needed to understand impacts on maternal and child health.


Sujet(s)
Sang foetal , Zéaralénone , Humains , Femelle , Sang foetal/composition chimique , Grossesse , Zéaralénone/urine , Zéaralénone/sang , Adulte , Mâle , Hormones sexuelles stéroïdiennes/sang , Exposition maternelle , Études de cohortes , Zéranol/analogues et dérivés , Zéranol/urine , Oestradiol/sang , Jeune adulte , Placenta/composition chimique
6.
Int J Hyg Environ Health ; 260: 114407, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38879913

RÉSUMÉ

BACKGROUND: Executive functions develop rapidly in childhood, enabling problem-solving, focused attention, and planning. Exposures to environmental toxicants in pregnancy may impair healthy executive function development in children. There is increasing concern regarding polycyclic aromatic hydrocarbons (PAHs) given their ability to transfer across the placenta and the fetal blood-brain barrier, yet evidence from epidemiological studies is limited. METHODS: We examined associations between prenatal PAH exposure and executive functions in 814 children of non-smoking mothers from two U.S. cohorts in the ECHO-PATHWAYS Consortium. Seven mono-hydroxylated PAH metabolites were measured in mid-pregnancy urine and analyzed individually and as mixtures. Three executive function domains were measured at age 8-9: cognitive flexibility, working memory, and inhibitory control. A composite score quantifying overall performance was further calculated. We fitted linear regressions adjusted for socio-demographics, maternal health behaviors, and psychological measures, and examined modification by child sex and stressful life events in pregnancy. Bayesian kernel machine regression was performed to estimate the interactive and overall effects of the PAH mixture. RESULTS: The results from primary analysis of linear regressions were generally null, and no modification by child sex or maternal stress was indicated. Mixture analyses suggested several pairwise interactions between individual PAH metabolites in varied directions on working memory, particularly interactions between 2/3/9-FLUO and other PAH metabolites, but no overall or individual effects were evident. CONCLUSION: We conducted a novel exploration of PAH-executive functions association in a large, combined sample from two cohorts. Although findings were predominantly null, the study carries important implications for future research and contributes to evolving science regarding developmental origins of diseases.


Sujet(s)
Fonction exécutive , Hydrocarbures aromatiques polycycliques , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Femelle , Hydrocarbures aromatiques polycycliques/urine , Grossesse , Fonction exécutive/effets des médicaments et des substances chimiques , Enfant , Mâle , Études de cohortes , Polluants environnementaux/urine , Adulte , Mémoire à court terme/effets des médicaments et des substances chimiques , Exposition maternelle
7.
Int J Hyg Environ Health ; 260: 114408, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38896984

RÉSUMÉ

BACKGROUND: Bisphenol A (BPA) is a well-known endocrine disrupter used in several consumer products. Restricted use of BPA has led to increased use of bisphenol F (BPF) and bisphenol S (BPS). While previous studies found no associations between prenatal BPA and BPF exposure and bone mineral density (BMD), two recent cohort studies found that prenatal BPS exposure was negatively associated with bone mineral density in the offspring. AIM: To determine possible associations between maternal and child urinary bisphenol concentrations, BMD and bone mineral content (BMC) in 7-year-old healthy children. METHODS: Pregnant women were recruited in 2010-2012 to participate in the Odense Child Cohort (OCC), Denmark. Maternal urine samples were collected in gestational week 28 and urinary BPA concentration was measured by isotope diluted LC-MS/MS. The children delivered a urine sample at age 7 years in which BPA, BPF and BPS were measured by an extended LS-MS/MS method based on the original method. At age 7 years DXA scans were performed and BMC and Z-score for BMD calculated. Associations between osmolality adjusted urinary maternal BPA and child BPA, BPF and BPS concentrations and BMC and BMD Z-score were examined by multiple linear regression analysis adjusted for potential confounders. Additionally, a combined effect of the bisphenols were evaluated by including the sum of child urinary BPA, BPF and BPS concentrations in the statistical analyses. RESULTS: A total of 546 mothers and 453 children aged 7 years participated. BPA was detected in 84% and 96% of the maternal and child urine samples, respectively. We found no significant association between maternal urinary BPA concentration during pregnancy and BMC and BMD Z-score in 7-year-old children. In addition, no association between current bisphenol exposure in tertiles and bone density was found, interestingly, current BPA and summed bisphenol exposure in the highest 10% was associated with lower BMD Z-score at age 7-years, statistically significant for boys. CONCLUSION: In these low exposed children we found no association between prenatal or current bisphenol exposure in tertiles and BMD in healthy children, however, the highest 10% exposed children had lower BMD, significant for boys, suggesting a negative impact with high bisphenol exposure. The short half-lives of bisphenols and the cross-sectional nature of the child exposure prompt more longitudinal studies to further clarify this topic.


Sujet(s)
Composés benzhydryliques , Densité osseuse , Phénols , Effets différés de l'exposition prénatale à des facteurs de risque , Sulfones , Humains , Phénols/urine , Enfant , Femelle , Composés benzhydryliques/urine , Composés benzhydryliques/effets indésirables , Densité osseuse/effets des médicaments et des substances chimiques , Mâle , Grossesse , Sulfones/urine , Sulfones/effets indésirables , Danemark , Études de cohortes , Perturbateurs endocriniens/urine , Perturbateurs endocriniens/effets indésirables , Polluants environnementaux/urine , Adulte , Exposition environnementale/effets indésirables , Exposition environnementale/analyse , Exposition maternelle/effets indésirables
8.
Cells ; 13(12)2024 Jun 09.
Article de Anglais | MEDLINE | ID: mdl-38920640

RÉSUMÉ

Exposure to cigarette smoke is known to induce disease during pregnancy. Recent evidence showed that exposure to secondhand smoke (SHS) negatively impacts fetal and placental weights, leading to the development of intrauterine growth restriction (IUGR). Electronic cigarettes (eCigs) represent a phenomenon that has recently emerged, and their use is also steadily rising. Even so, the effects of SHS or eCigs during gestation remain limited. In the present study, we wanted to characterize the effects of SHS or eCig exposure at two different important gestational points during mouse pregnancy. C57/Bl6 mice were exposed to SHS or eCigs via a nose-only delivery system for 4 days (from 14.5 to 17.5 gestational days (dGA) or for 6 days (from 12.5 dGA to 17.5 dGA)). At the time of necropsy (18.5 dGA), placental and fetal weights were recorded, maternal blood pressure was determined, and a dipstick test to measure proteinuria was performed. Placental tissues were collected, and inflammatory molecules in the placenta were identified. Treatment with SHS showed the following: (1) a significant decrease in placental and fetal weights following four days of exposure, (2) higher systolic and diastolic blood pressure following six days of exposure, and (3) increased proteinuria after six days of exposure. Treatment with eCigs showed the following: (1) a significant decrease in placental weight and fetal weight following four or six days of exposure, (2) higher systolic and diastolic blood pressure following six days of exposure, and (3) increased proteinuria after six days of exposure. We also observed different inflammatory markers associated with the development of IUGR or PE. We conclude that the detrimental effects of SHS or eCig treatment coincide with the length of maternal exposure. These results could be beneficial in understanding the long-term effects of SHS or eCig exposure in the development of placental diseases.


Sujet(s)
Souris de lignée C57BL , Placenta , Pollution par la fumée de tabac , Grossesse , Femelle , Animaux , Pollution par la fumée de tabac/effets indésirables , Souris , Placenta/effets des médicaments et des substances chimiques , Placenta/anatomopathologie , Maladies du placenta/anatomopathologie , Maladies du placenta/induit chimiquement , Vapeur des e-cigarettes/effets indésirables , Exposition maternelle/effets indésirables , Pression sanguine/effets des médicaments et des substances chimiques , Retard de croissance intra-utérin/induit chimiquement , Dispositifs électroniques d'administration de nicotine
9.
Front Public Health ; 12: 1356830, 2024.
Article de Anglais | MEDLINE | ID: mdl-38841656

RÉSUMÉ

Introduction: Exposure to indoor air pollution such as biomass fuel and particulate matter is a significant cause of adverse pregnancy outcomes. However, there is limited information about the association between indoor air pollution exposure and adverse pregnancy outcomes in low and middle-income countries. Therefore, this meta-analysis aimed to determine the association between indoor air pollution exposure and adverse pregnancy outcomes in low and middle-income countries. Methods: International electronic databases such as PubMed, Science Direct, Global Health, African Journals Online, HINARI, Semantic Scholar, and Google and Google Scholar were used to search for relevant articles. The study was conducted according to the updated Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A random effect model at a 95% confidence interval was used to determine the association between indoor air pollution exposure and adverse pregnancy outcomes using STATA version 14. Funnel plot and Higgs I2 statistics were used to determine the publication bias and heterogeneity of the included studies, respectively. Results: A total of 30 articles with 2,120,228 study participants were included in this meta-analysis. The pooled association between indoor air pollution exposure and at least one adverse pregnancy outcome was 15.5% (95%CI: 12.6-18.5), with significant heterogeneity (I2 = 100%; p < 0.001). Exposure to indoor air pollution increased the risk of small for gestational age by 23.7% (95%CI: 8.2-39.3) followed by low birth weight (17.7%; 95%CI: 12.9-22.5). Exposure to biomass fuel (OR = 1.16; 95%CI: 1.12-1.2), particulate matter (OR = 1.28; 95%CI: 1.25-1.31), and kerosene (OR = 1.38; 95%CI: 1.09-1.66) were factors associated with developing at least one adverse pregnancy outcomes. Conclusions: We found that more than one in seven pregnant women exposed to indoor air pollution had at least one adverse pregnancy outcome. Specifically, exposure to particulate matter, biomass fuel, and kerosene were determinant factors for developing at least one adverse pregnancy outcome. Therefore, urgent comprehensive health intervention should be implemented in the area to reduce adverse pregnancy outcomes.


Sujet(s)
Pollution de l'air intérieur , Pays en voie de développement , Issue de la grossesse , Humains , Pollution de l'air intérieur/effets indésirables , Grossesse , Femelle , Issue de la grossesse/épidémiologie , Matière particulaire/effets indésirables , Exposition maternelle/effets indésirables , Exposition maternelle/statistiques et données numériques
10.
J Environ Sci (China) ; 145: 75-87, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-38844325

RÉSUMÉ

Prednisone is a synthetic glucocorticoid that is commonly used in both human and veterinary medication. Now, it is also recognized as an emerging environmental contaminant. Pregnant women may be exposed to prednisone actively or passively through multiple pathways and cause developmental toxicity to the fetus. However, the impact of prenatal prednisone exposure (PPE) on fetal kidney development remains unclear. In this study, pregnant mice were administered prednisone intragastrically during full-term pregnancy with different doses (0.25, 0.5, or 1 mg/(kg·day)), or at the dose of 1 mg/(kg·day) in different gestational days (GD) (GD0-9, GD10-18, or GD0-18). The pregnant mice were euthanized on GD18. HE staining revealed fetal kidney dysplasia, with an enlarged glomerular Bowman's capsule space and a reduced capillary network in the PPE groups. The expression of the podocyte and the mesangial cell marker genes was significantly reduced in the PPE groups. However, overall gene expression in renal tubules and collecting ducts were markedly increased. All of the above effects were more pronounced in high-dose, full-term pregnancy, and female fetuses. Studies on the mechanism of the female fetal kidney have revealed that PPE reduced the expression of Six2, increased the expression of Hnf1ß, Hnf4α, and Wnt9b, and inhibited the expression of glial cell line-derived neurotrophic factor (GDNF) and Notch signaling pathways. In conclusion, this study demonstrated that there is a sex difference in the developmental toxicity of PPE to the fetal kidney, and the time effect is manifested as full-term pregnancy > early pregnancy > mid-late pregnancy.


Sujet(s)
Rein , Prednisone , Femelle , Animaux , Grossesse , Souris , Rein/effets des médicaments et des substances chimiques , Rein/embryologie , Prednisone/toxicité , Développement foetal/effets des médicaments et des substances chimiques , Mâle , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Exposition maternelle/effets indésirables
11.
Front Public Health ; 12: 1396251, 2024.
Article de Anglais | MEDLINE | ID: mdl-38855453

RÉSUMÉ

Attention deficit hyperactivity disorder (ADHD), a prevalent neurodevelopmental disorder in children, originates from a multifaceted interplay of genetic, neurological, and environmental factors. Recent studies have increasingly concentrated on environmental determinants, notably air pollution, and their impact on the risk of developing ADHD. Additionally, previous research has often conflated clinically diagnosed ADHD cases with instances of mere ADHD-like symptoms, a methodology that can introduce bias and obscure the true relationship between environmental factors and ADHD. To address this oversight, our systematic review meticulously investigates the relationship between both prenatal and postnatal exposures to particular air pollutants and strictly clinically diagnosed ADHD. Our comprehensive review encompassed 801 studies from PubMed, Cochrane Library, Web of Science, and Embase databases, out of which eight met our rigorous inclusion criteria. The Newcastle-Ottawa Scale (NOS) was utilized to gauge quality and bias. Our review found substantiated the connection between prenatal exposure to PM2.5 and NOx and a heightened risk of ADHD, while exposure to PM10 during the prenatal stage was not associated with ADHD. These findings hint at varied health impacts from different particulate matters and the prospect of gender-specific susceptibilities to such exposures. We also identified an association between postnatal exposure to PM2.5, PM10, and NO2 and an increased ADHD risk, underlining the potential neurodevelopmental harms from early exposure to these pollutants. These relationships, seemingly intricate and potentially dose-dependent, underscore the need for more detailed scrutiny. The unique value of our review is in its detailed exploration of the association between specific air pollution exposures and clinically diagnosed ADHD. Our findings offer much-needed clarity in this complex domain and emphasize the importance of future research to standardize exposure and outcome metrics, probe potential mechanisms, and reduce bias and heterogeneity.


Sujet(s)
Pollution de l'air , Trouble déficitaire de l'attention avec hyperactivité , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Trouble déficitaire de l'attention avec hyperactivité/étiologie , Grossesse , Pollution de l'air/effets indésirables , Femelle , Polluants atmosphériques/effets indésirables , Exposition environnementale/effets indésirables , Matière particulaire/effets indésirables , Enfant , Mâle , Exposition maternelle/effets indésirables
12.
J Obstet Gynaecol ; 44(1): 2362962, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-38853776

RÉSUMÉ

BACKGROUND: Gestational diabetes mellitus (GDM) can have negative effects on both the pregnancy and perinatal outcomes, as well as the long-term health of the mother and the child. It has been suggested that exposure to air pollution may increase the risk of developing GDM. This study investigated the relationship between exposure to air pollutants with gestational diabetes. METHODS: The present study is a retrospective cohort study. We used data from a randomised community trial conducted between September 2016 and January 2019 in Iran. During this period, data on air pollutant levels of five cities investigated in the original study, including 6090 pregnant women, were available. Concentrations of ozone (O3), nitric oxide (NO), nitrogen dioxide (NO2), nitrogen oxides (NOx), sulphur dioxide (SO2), carbon monoxide (CO), particulate matter < 2.5 (PM2.5) or <10 µm (PM10) were obtained from air pollution monitoring stations. Exposure to air pollutants during the three months preceding pregnancy and the first, second and third trimesters of pregnancy for each participant was estimated. The odds ratio was calculated based on logistic regression in three adjusted models considering different confounders. Only results that had a p < .05 were considered statistically significant. RESULTS: None of the logistic regression models showed any statistically significant relationship between the exposure to any of the pollutants and GDM at different time points (before pregnancy, in the first, second and third trimesters of pregnancy and 12 months in total) (p > .05). Also, none of the adjusted logistic regression models showed any significant association between PM10 exposure and GDM risk at all different time points after adjusting for various confounders (p > .05). CONCLUSIONS: This study found no association between GDM risk and exposure to various air pollutants before and during the different trimesters of pregnancy. This result should be interpreted cautiously due to the lack of considering all of the potential confounders.


The health of pregnant women and their children can be impacted by gestational diabetes mellitus (GDM), one of the prevalent pregnancy complications. Some of studies showed that the incidence of gestational diabetes can be influenced by genetic or environmental factors. Air pollution is an environmental stimulus that may predispose pregnant women to GDM. This research explored whether air pollution could increase the risk of developing gestational diabetes. Over 6000 pregnant women in five cities of Iran participated in the study and were screened for gestational diabetes. Their exposure to the various air pollutants during the three months preceding pregnancy and total pregnancy period was measured. In this study, we found no clear association between air pollution and gestational diabetes. However, this finding needs to be interpreted cautiously since all the influential factors were not assessed.


Sujet(s)
Polluants atmosphériques , Pollution de l'air , Diabète gestationnel , Matière particulaire , Humains , Femelle , Grossesse , Diabète gestationnel/épidémiologie , Pollution de l'air/effets indésirables , Pollution de l'air/statistiques et données numériques , Pollution de l'air/analyse , Études rétrospectives , Adulte , Polluants atmosphériques/effets indésirables , Polluants atmosphériques/analyse , Iran/épidémiologie , Matière particulaire/effets indésirables , Matière particulaire/analyse , Dioxyde d'azote/analyse , Dioxyde d'azote/effets indésirables , Modèles logistiques , Ozone/analyse , Ozone/effets indésirables , Exposition maternelle/effets indésirables , Exposition maternelle/statistiques et données numériques , Exposition environnementale/effets indésirables , Facteurs de risque
13.
J Matern Fetal Neonatal Med ; 37(1): 2356038, 2024 12.
Article de Anglais | MEDLINE | ID: mdl-38830822

RÉSUMÉ

OBJECTIVE: Evaluation of neonatal morbidity after maternal central neurotropic drug exposure. METHODS: Retrospective single-center level-III neonatology cohort analysis of neonates after CND from 2018 to 2021. Control group of neonates born to mothers without CND cared for at the maternity ward. RESULTS: Significantly more frequent therapy need of neonates with CND [OR 23 (95% CI: 7.8-62); RR 14 (95% CI: 5.4-37); p < 0.01]. Neonates after CND had lower Apgar-scores LM 1 [CND 8.1; CG 8.6; p < 0.05]; LM 5 [CND 9; CG 9.7; p < 0.01]; LM 10 [CND 9.6; CG 9.9; p < 0.05]. The first symptom occurred in 95.35% within 24 h (mean: 3.3 h). CND group showed significantly more often preterm delivery [OR 3.5; RR 3.2; p < 0.05], and especially cumulative multiple symptoms [OR 9.4; RR 6.6; p < 0.01] but no correlation to multiple maternal medication use (p = 0.3). CONCLUSIONS: Neonates exposed to CND are at increased risk for postnatal therapy, often due to multiple symptoms. Neonates should be continuously monitored for at least 24 h.


Sujet(s)
Maladies néonatales , Humains , Femelle , Nouveau-né , Études rétrospectives , Grossesse , Adulte , Mâle , Maladies néonatales/épidémiologie , Maladies néonatales/induit chimiquement , Agents du système nerveux central/effets indésirables , Agents du système nerveux central/usage thérapeutique , Effets différés de l'exposition prénatale à des facteurs de risque/épidémiologie , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Études cas-témoins , Exposition maternelle/effets indésirables , Complications de la grossesse/traitement médicamenteux , Complications de la grossesse/épidémiologie
14.
Nutrients ; 16(11)2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38892490

RÉSUMÉ

During the last decades, endocrine-disrupting chemicals (EDCs) have attracted the attention of the scientific community, as a result of a deepened understanding of their effects on human health. These compounds, which can reach populations through the food chain and a number of daily life products, are known to modify the activity of the endocrine system. Regarding vulnerable groups like pregnant mothers, the potential damage they can cause increases their importance, since it is the health of two lives that is at risk. EDCs can affect the gestation process, altering fetal development, and eventually inducing the appearance of many disorders in their childhood and/or adulthood. Because of this, several of these substances have been studied to clarify the influence of their prenatal exposure on the cognitive and psychomotor development of the newborn, together with the appearance of non-communicable diseases and other disorders. The most novel research on the subject has been gathered in this narrative review, with the aim of clarifying the current knowledge on the subject. EDCs have shown, through different studies involving both animal and human investigation, a detrimental effect on the development of children exposed to the during pregnancy, sometimes with sex-specific outcomes. However, some other studies have failed to find these associations, which highlights the need for deeper and more rigorous research, that will provide an even more solid foundation for the establishment of policies against the extended use of these chemicals.


Sujet(s)
Perturbateurs endocriniens , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Perturbateurs endocriniens/effets indésirables , Perturbateurs endocriniens/toxicité , Grossesse , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Femelle , Animaux , Développement de l'enfant/effets des médicaments et des substances chimiques , Mâle , Exposition maternelle/effets indésirables , Développement foetal/effets des médicaments et des substances chimiques , Nouveau-né
15.
Nat Commun ; 15(1): 5312, 2024 Jun 21.
Article de Anglais | MEDLINE | ID: mdl-38906856

RÉSUMÉ

Drug exposure during pregnancy lacks global fetal safety data. The maternal drug exposure birth cohort (DEBC) study, a prospective longitudinal investigation, aims to explore the correlation of maternal drug exposure during pregnancy with pregnancy outcomes, and establish a human biospecimen biobank. Here we describe the process of establishing DEBC and show that the drug exposure rate in the first trimester of pregnant women in DEBC (n = 112,986) is 30.70%. Among the drugs used, dydrogesterone and progesterone have the highest exposure rates, which are 11.97% and 10.82%, respectively. The overall incidence of adverse pregnancy outcomes is 13.49%. Dydrogesterone exposure during the first trimester is correlated with higher incidences of stillbirth, preterm birth, low birth weight, and birth defects, along with a lower incidence of miscarriage/abortion. Due to the limitations of this cohort study, causative conclusions cannot be drawn. Further follow-up and in-depth data analysis are planned for future studies.


Sujet(s)
Exposition maternelle , Issue de la grossesse , Premier trimestre de grossesse , Naissance prématurée , Humains , Femelle , Grossesse , Chine/épidémiologie , Exposition maternelle/effets indésirables , Adulte , Naissance prématurée/épidémiologie , Études prospectives , Issue de la grossesse/épidémiologie , Dydrogestérone/effets indésirables , Progestérone , Cohorte de naissance , Nouveau-né , Avortement spontané/épidémiologie , Avortement spontané/induit chimiquement , Mortinatalité/épidémiologie , Nourrisson à faible poids de naissance , Études longitudinales , Incidence , Jeune adulte
16.
J Hazard Mater ; 475: 134876, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38870858

RÉSUMÉ

This study exposed adult Sydney rock oysters, of either sex or both, to the synthetic estrogen 17α-ethinylestradiol (EE2) at 50 ng/L for 21 days, followed by an examination of developmental endpoints and transcriptomic responses in unexposed larvae. Reduced survival was observed at 1 day post-fertilisation (dpf) in larvae from bi-parental exposure (FTMT). Motile larvae at 2 dpf were fewer from maternal (FTMC), paternal (FCMT), and FTMT exposures. Additionally, shell length at 7 dpf decreased in larvae from FTMC and FTMT parents. RNA sequencing (RNA-seq) revealed 1064 differentially expressed genes (DEGs) in 1-dpf larvae from FTMT parents, while fewer DEGs were detected in larvae from FTMC and FCMT parents, with 258 and 7, respectively. GO and KEGG analyses showed significant enrichment of DEGs in diverse terms and pathways, with limited overlap among treatment groups. IPA results indicated potential inhibition of pathways regulating energy production, larval development, transcription, and detoxification of reactive oxygen species in FTMT larvae. qRT-PCR validation confirmed significant downregulation of selected DEGs involved in these pathways and relevant biological processes, as identified in the RNA-seq dataset. Overall, our results suggest that the intergenerational toxicity of EE2 is primarily maternally transmitted, with bi-parental exposure amplifying these effects.


Sujet(s)
Éthinyloestradiol , Larve , Ostreidae , Transcriptome , Polluants chimiques de l'eau , Animaux , Éthinyloestradiol/toxicité , Larve/effets des médicaments et des substances chimiques , Larve/croissance et développement , Transcriptome/effets des médicaments et des substances chimiques , Ostreidae/effets des médicaments et des substances chimiques , Ostreidae/croissance et développement , Ostreidae/génétique , Femelle , Polluants chimiques de l'eau/toxicité , Mâle , Exposition maternelle , Exposition paternelle/effets indésirables
17.
J Hazard Mater ; 474: 134800, 2024 Aug 05.
Article de Anglais | MEDLINE | ID: mdl-38850955

RÉSUMÉ

Microplastics have emerged as a prominent global environmental contaminant, and they have been found in both human placenta and breast milk. However, the potential effects and mechanisms of maternal exposure to microplastics at various gestational stages on offspring neurodevelopment remain poorly understood. This investigation delves into the potential neurodevelopmental ramifications of maternal exposure to polystyrene nanoplastics (PS-NPs) during distinct phases of pregnancy and lactation. Targeted metabolomics shows that co-exposure during both pregnancy and lactation primarily engendered alterations in monoamine neurotransmitters within the cortex and amino acid neurotransmitters within the hippocampus. After prenatal exposure to PS-NPs, fetal rats showed appreciably diminished cortical thickness and heightened cortical cell proliferation. However, this exposure did not affect the neurodifferentiation of radial glial cells and intermediate progenitor cells. In addition, offspring are accompanied by disordered neocortical migration, typified by escalated superficial layer neurons proliferation and reduced deep layer neurons populations. Moreover, the hippocampal synapses showed significantly widened synaptic clefts and diminished postsynaptic density. Consequently, PS-NPs culminated in deficits in anxiolytic-like behaviors and spatial memory in adolescent offspring, aligning with concurrent neurotransmitter and synaptic alterations. In conclusion, this study elucidates the sensitive windows of early-life nanoplastic exposure and the consequential impact on offspring neurodevelopment.


Sujet(s)
Lactation , Exposition maternelle , Effets différés de l'exposition prénatale à des facteurs de risque , Animaux , Femelle , Grossesse , Lactation/effets des médicaments et des substances chimiques , Exposition maternelle/effets indésirables , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/croissance et développement , Polystyrènes/toxicité , Mâle , Microplastiques/toxicité , Rat Sprague-Dawley , Rats , Neurones/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Agents neuromédiateurs/métabolisme , Nanoparticules/toxicité , Encéphale/effets des médicaments et des substances chimiques , Encéphale/croissance et développement
18.
Environ Sci Technol ; 58(25): 10910-10919, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38862419

RÉSUMÉ

With the widespread use of bisphenol A (BPA) analogs, their health risks have attracted attention. The effects of maternal BPA analogs exposure on glucose homeostasis in adult offspring and the underlying fetal origins require further exploration. Herein, we exposed pregnant mice to two types of BPA analogs─BPB and BPAF; we evaluated glucose homeostasis in adult offspring and maternal-fetal glucose transport by testing intraperitoneal glucose tolerance, determining glucose and glycogen contents, conducting positron emission tomography (PET)/computed tomography (CT), detecting expression of placental nutrient transport factors, and assessing placental barrier status. We observed that adult female offspring maternally exposed to BPB and BPAF exhibited low fasting blood glucose in adulthood, with even abnormal glucose tolerance in the BPAF group. This phenomenon can be traced back to the elevated fetal glucose induced by the increased efficiency of placenta glucose transport in late pregnancy. On the other hand, the expression of genes associated with vascular development and glucose transport was significantly altered in the placenta in the BPAF group, potentially contributing to enhanced fetal glucose. These findings provide preliminary insights into potential mechanisms underlying the disturbance of glucose metabolism in adult female offspring mice induced by maternal exposure to BPA analogs.


Sujet(s)
Composés benzhydryliques , Exposition maternelle , Phénols , Femelle , Animaux , Souris , Grossesse , Phénols/toxicité , Composés benzhydryliques/toxicité , Glucose/métabolisme , Placenta/métabolisme , Placenta/effets des médicaments et des substances chimiques , Foetus/effets des médicaments et des substances chimiques , Effets différés de l'exposition prénatale à des facteurs de risque
19.
Sci Rep ; 14(1): 13762, 2024 06 14.
Article de Anglais | MEDLINE | ID: mdl-38877103

RÉSUMÉ

Selective Serotonin Reuptake Inhibitor (SSRI) therapy is common among perinatal populations for the treatment of mood disorders. Medications can affect diversity and composition of the gut microbiome, which plays a key role in modulating health. While previous studies have examined the effects of antidepressant exposure on the maternal gut microbiome, whether SSRI exposure affects the offspring gut microbiome is unknown. We investigated the effects of maternal fluoxetine exposure on the gut microbiome of maternal and offspring mice during pregnancy and lactation (embryonic day 10-lactation day 21; E10-L21). Stool samples collected on E17, L11, L15, and L21 were examined using 16S rRNA sequencing. Our results suggest that maternal fluoxetine exposure may result in decreased alpha diversity of the offspring gut microbiome in early life. Furthermore, we observed several genera-specific differences in the gut microbiome based on treatment, specifically of Turicibacter, Parasutterella, and Romboutsia. These findings support our understanding of gut health, as dysbiotic development of the gut microbiome has been associated with local and systemic health problems including gastrointestinal morbidities and interrupted growth patterns in infants. Future research should pursue study in human populations and those at high risk for gut microbial dysbiosis and intestinal injury.


Sujet(s)
Fluoxétine , Microbiome gastro-intestinal , Lactation , ARN ribosomique 16S , Animaux , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Femelle , Grossesse , Lactation/effets des médicaments et des substances chimiques , Fluoxétine/pharmacologie , Fluoxétine/effets indésirables , Souris , ARN ribosomique 16S/génétique , Effets différés de l'exposition prénatale à des facteurs de risque/microbiologie , Inbiteurs sélectifs de la recapture de la sérotonine/effets indésirables , Inbiteurs sélectifs de la recapture de la sérotonine/pharmacologie , Fèces/microbiologie , Exposition maternelle/effets indésirables , Bactéries/effets des médicaments et des substances chimiques , Bactéries/classification , Bactéries/génétique , Bactéries/isolement et purification
20.
Sci Rep ; 14(1): 13752, 2024 06 14.
Article de Anglais | MEDLINE | ID: mdl-38877153

RÉSUMÉ

OPFRs are emerging environmental pollutants with reproductive and endocrine toxicity. This study aimed to examine the association between environmental exposure to OPFRs during early pregnancy and GDM. This nested case-control study was based on a birth cohort that was constructed at a maternal and child health hospital, including 74 cases of GDM among 512 pregnant women. The OPFRs, including TBP, TBEP, TCEP, TDCPP, TMCP, TOCP, and TPHP during 10-14 weeks of pregnancy were determined using GC-MS. The association between the OPFRs and GDM was assessed using WQS and BKMR models. The levels of OPFRs were significantly elevated in GDM patients (60) compared with the controls (90). The WQS analysis showed that mixtures of the OPFRs were significantly associated with GDM (OR 1.370, 95% CI 1.036-1.810, P = 0.027), and TBP, TPHP, and TMCP were the major contributors to the mixed exposure effect. In the BKMR model, individual exposure to TBP, TPHP, and TMCP, and the interaction of TMCP with TBP and TPHP were significantly associated with GDM. Environmental exposure to OPFRs is positively associated with GDM. These findings provide evidence for the adverse effects of OPFR exposure on the health of pregnant women.


Sujet(s)
Diabète gestationnel , Exposition environnementale , Ignifuges , Humains , Grossesse , Femelle , Diabète gestationnel/épidémiologie , Diabète gestationnel/induit chimiquement , Études cas-témoins , Ignifuges/effets indésirables , Ignifuges/analyse , Adulte , Exposition environnementale/effets indésirables , Exposition maternelle/effets indésirables , Composés organiques du phosphore/effets indésirables , Polluants environnementaux/effets indésirables , Facteurs de risque , Premier trimestre de grossesse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...